Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12â€ƒmonths.
Epilepsia., Nov (2012)
Recommendations for the Return of Research Results to Study Participants and Guardians: A Report From the Children's Oncology Group.
J. Clin. Oncol., Oct (2012)
Challenges and opportunities in childhood cancer drug development.
Nat. Rev. Cancer., Nov;12(11):776-82 (2012)
Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Consortium Study.
Clin. Cancer Res., Nov;18(21):6058-64 (2012)
A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report.
Clin. Cancer Res., Nov;18(21):6011-6022 (2012)
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report.
Clin. Cancer Res., Sep;18(18):5081-9 (2012)
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study.
Pediatr Blood Cancer., Feb;60(2):237-41 (2013)
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncolo
Pharmacoepidemiol Drug Saf., May;21 Suppl 2:37-43 (2012)
Sporadic adenocarcinoma of the colon in children: case series and review of the literature.
J. Pediatr. Hematol. Oncol., May;34(4):e137-41 (2012)
Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.
Clin. Cancer Res., Mar;18(6):1547-54 (2012)
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.
J. Clin. Oncol., Jan;30(3):256-62 (2012)
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.
Cancer Chemother. Pharmacol., Apr;69(4):1021-7 (2012)
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
Eur. J. Cancer., Mar;48(4):579-85 (2012)
Quantification of serum fentanyl concentrations from umbilical cord blood during ex utero intrapartum therapy.
Anesth. Analg., Jun;114(6):1265-7 (2012)
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
Pediatr Blood Cancer., Mar;58(3):362-5 (2012)
Preclinical evaluation of pemetrexed in pediatric solid tumors.
Pediatr Blood Cancer., Dec;57(7):1233-5 (2011)
A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.
Neuro-oncology., Aug;13(8):910-5 (2011)
Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.
Clin. Cancer Res., Aug;17(15):5113-22 (2011)
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
Cancer Chemother. Pharmacol., Dec;68(6):1469-75 (2011)
Prescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidance.
BMC Pediatr., 11:25 (2011)